Davis's Drug Guide
brensocatib
General
Pronunciation:
bren-so-ka-tib
Trade Name(s)
- Brinsupri
Ther. Class.
none assigned
Pharm. Class.
temporary class
dipeptidyl peptidase 1 inhibitorThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Brensocatib." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580162/all/brensocatib.
Vallerand AHA, Sanoski CAC. Brensocatib. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580162/all/brensocatib. Accessed August 4, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Brensocatib. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580162/all/brensocatib
Vallerand AHA, Sanoski CAC. Brensocatib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 04]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580162/all/brensocatib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - brensocatib
ID - 3580162
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580162/all/brensocatib
PB - F.A. Davis Company
ET - 20
DB - The Washington Manual
DP - Unbound Medicine
ER -
